• No se han encontrado resultados

AJM American Journal of Medicine AJPH American Journal of Public Health

AJRCCM American Journal of Respiratory and Critical Care Medicine CDSR Cochrane Database of Systematic Reviews

CMAJ Canadian Medical Association Journal

IJCOPD International Journal of Chronic Obstructive Pulmonary Disease JECH Journal of Epidemiology and Community Health

MMWR Morbidity and Mortality Weekly Report NEJM New England Journal of Medicine

REFERENCES

An, L. C., Schillo, B. A., Kavanaugh, A. M., Lachter, R. B., Luxenberg, M. G., Wendling, A. H., & Joseph, A. M. (2006). Increased reach and effectiveness of a statewide tobacco quitline after the addition of access to free nicotine replacement therapy. Tobacco Control, 15(4), 286–293.

Barnes, J., Dong, C. Y., McRobbie, H., Walker, N., Mehta, M., & Stead, L. F. (2010). Hypnotherapy for smoking cessation. CDSR, (10), CD001008.

Benowitz, N. L. (2008). Neurobiology of nicotine addiction: implications for smoking cessation treatment. AJM, 121(4 Suppl 1), S3–10.

Benowitz, N. L. (2010). Nicotine addiction. NEJM, 362(24), 2295–2303.

Borland, R., Partos, T. R., & Cummings, K. M. (2012). Systematic biases in cross- sectional community studies may underestimate the effectiveness of stop-smoking medications. Nicotine & Tobacco Research, 14(12), 1483–1487.

Burton, S. L., Gitchell, J. G., Shiffman, S. (2000). Use of FDA-approved pharmacologic treatments for tobacco dependence--United States, 1984-1998. MMWR, 49(29), 665–668.

Cahill, K., Stevens, S., Perera, R., & Lancaster, T. (2013). Pharmacological interventions for smoking cessation: an overview and network meta-analysis. CDSR, 5,

CD009329.

Cancer Research UK. (2012, May 25). Smoking and cancer: What’s in a cigarette? Retrieved January 7, 2014, from http://www.cancerresearchuk.org/cancer- info/healthyliving/smokingandtobacco/whatsinacigarette/smoking-and-cancer- whats-in-a-cigarette

Carmody, T. P., Duncan, C., Simon, J. A., Solkowitz, S., Huggins, J., Lee, S., &

Delucchi, K. (2008). Hypnosis for smoking cessation: a randomized trial. Nicotine

& Tobacco Research, 10(5), 811–818.

Centers for Disease Control and Prevention (CDC). (2008). Smoking-attributable

mortality, years of potential life lost, and productivity losses — United States, 2000- 2004. MMWR, 57(45), 1226–1228.

CDC, (2011). Quitting Smoking Among Adults — United States, 2001-2010. MMWR,

CDC, (2013a, September 9). More than 100,000 Americans quit smoking due to national media campaign. Retrieved February 1, 2014, from

http://www.cdc.gov/media/releases/2013/p0909-tips-campaign-results.html

CDC, (2013b, November 14). Trends in Current Cigarette Smoking Among High School Students and Adults, United States, 1965–2011. Retrieved January 10, 2014, from http://www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking/

CDC, (2014a). Current Cigarette Smoking Among Adults — United States, 2005–2012.

MMWR, 63(2), 29–34.

CDC, (2014b, February 24). Lung Cancer. Retrieved March 2, 2014, from http://www.cdc.gov/cancer/lung/

CDC, (n.d.) Selected Actions of the U.S. Government Regarding the Regulation of Tobacco Sales, Marketing, and Use. Retrieved February 8, 2014, from

http://www.cdc.gov/tobacco/data_statistics/by_topic/policy/legislation/

Cryan, J. F., Bruijnzeel, A. W., Skjei, K. L., & Markou, A. (2003). Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology, 168(3), 347–358.

Dwoskin, L. P., Rauhut, A. S., King-Pospisil, K. A., & Bardo, M. T. (2006). Review of the pharmacology and clinical profile of bupropion, an antidepressant and tobacco use cessation agent. CNS Drug Reviews, 12(3-4), 178–207.

Edwards, S. A., Bondy, S. J., Callaghan, R. C., & Mann, R. E. (2014). Prevalence of unassisted quit attempts in population-based studies: A systematic review of the literature. Addictive Behaviors, 39(3), 512–519.

Epping-Jordan, M. P., Watkins, S. S., Koob, G. F., & Markou, A. (1998). Dramatic decreases in brain reward function during nicotine withdrawal. Nature, 393(6680), 76–79.

Fischer, B. M., Pavlisko, E., & Voynow, J. A. (2011). Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. IJCOPD, 6, 413–421.

Frieden, T. R., Mostashari, F., Kerker, B. D., Miller, N., Hajat, A., & Frankel, M. (2005). Adult Tobacco Use Levels After Intensive Tobacco Control Measures: New York City, 2002-2003. AJPH, 95(6), 1016–1023.

Ghio, A. J., Hilborn, E. D., Stonehuerner, J. G., Dailey, L. A., Carter, J. D., Richards, J. H., Pinkerton, K. E. (2008). Particulate Matter in Cigarette Smoke Alters Iron Homeostasis to Produce a Biological Effect. AJRCCM, 178(11), 1130–1138. Gibbons, D. L., Byers, L. A., & Kurie, J. M. (2014). Smoking, p53 Mutation, and Lung

Cancer. Molecular Cancer Research, 12(1), 3–13.

Gilpin, E. A., Pierce, J. P., & Farkas, A. J. (1997). Duration of smoking abstinence and success in quitting. Journal of the National Cancer Institute, 89(8), 572–576. Godtfredsen, N. S., & Prescott, E. (2011). Benefits of smoking cessation with focus on

cardiovascular and respiratory comorbidities. The Clinical Respiratory Journal,

5(4), 187–194.

Hecht, S. S. (n.d.). Metabolism of Carcinogenic Tobacco-Specific Nitrosamines. Retrieved January 23, 2014, from

http://www.cancer.gov/researchandfunding/MERIT/Hecht

Herd, N., Borland, R., & Hyland, A. (2009). Predictors of smoking relapse by duration of abstinence: findings from the International Tobacco Control (ITC) Four Country Survey. Addiction, 104(12), 2088–2099.

Lichtenstein, E., Zhu, S.-H., & Tedeschi, G. J. (2010). Smoking Cessation Quitlines. The

American Psychologist, 65(4), 252–261.

National Heart, Lung, and Blood Institute (NHLBI). (2013, July 31). What Is COPD? Retrieved February 12, 2014, from http://www.nhlbi.nih.gov/health/health- topics/topics/copd/

National Institute of Health (NIH). (2012, March 2). Nearly 800,000 deaths prevented due to declines in smoking. Retrieved February 16, 2014, from

http://www.nih.gov/news/health/mar2012/nci-14.htm

Nestler, E. J. (2005). Is there a common molecular pathway for addiction? Nature

Neuroscience, 8(11), 1445–1449.

Pear, R. (2013, September 17). Percentage of Americans Lacking Health Coverage Falls Again. The New York Times. Retrieved from

http://www.nytimes.com/2013/09/18/us/percentage-of-americans-lacking-health- coverage-falls-again.html

Pons, S., Fattore, L., Cossu, G., Tolu, S., Porcu, E., McIntosh, J., Fratta, W. (2008). Crucial role of  α4 and  α6 nicotinic acetylcholine receptor subunits from ventral

tegmental area in systemic nicotine self-administration. Journal of Neuroscience,

28(47), 12318.

Saul, J., Davis, R. (2013, October 23). FY2012 NAQC Annual Survey Results. Retrieved from

http://c.ymcdn.com/sites/www.naquitline.org/resource/resmgr/2012_annual_survey/ final1oct23pptnaqc_2012_fina.pdf

Singh, S., Loke, Y. K., Spangler, J. G., & Furberg, C. D. (2011). Risk of serious adverse cardiovascular events associated with Varenicline: a systematic review and meta- analysis. CMAJ, 183(12), 1359–1366.

Stead, L. F., Perera, R., Bullen, C., Mant, D., Hartmann-Boyce, J., Cahill, K., & Lancaster, T. (2012). Nicotine replacement therapy for smoking cessation. CDSR,

11, CD000146.

Substance Abuse and Mental Health Services Administration (SAMHSA). (2013). Results from the 2012 National Survey on Drug Use and Health: Summary of National Findings. NSDUH Series H-46, HHS Publication No, 13-4795.

Takagi, H., & Umemoto, T. (2011). Varenicline: quantifying the risk. CMAJ, 183(12), 1404–1404.

U.S. Department of Health and Human Services (USDHHS). (2010). How Tobacco

Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease: A Report of the Surgeon General. Atlanta (GA): Centers for Disease

Control and Prevention, Office on Smoking and Health. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK53017/

USDHHS (2014). The Health Consequences of Smoking—50 Years of Progress: A

Report of the Surgeon General. Atlanta (GA): CDC, Office on Smoking and Health.

Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK179276/

U.S. Food and Drug Administration (FDA). (2012). Protecting the Public Health through Tobacco Regulation. Retrieved February 8, 2014, from

http://www.fda.gov/TobaccoProducts/Labeling/TobaccoProductReviewEvaluation/u cm313854.htm

U.S. National Library of Medicine (NLM). (n.d.) The Reports of the Surgeon General: The 1964 Report on Smoking and Health. Retrieved February 18, 2014, from http://profiles.nlm.nih.gov/NN/Views/Exhibit/narrative/smoking.html

Vartiainen, E., Seppala, T., Lillsunde, P., & Puska, P. (2002). Validation of self reported smoking by serum cotinine measurement in a community-based study. JECH, 56(3), 167–170.

VITA